Published on
December 23, 2025
- 17:00 GMT
Cellens Raises $6.5M to Advance Its AI-Driven Mechanobiology Platform for Non-Invasive Bladder Cancer Diagnostics
BOSTON, MA, UNITED STATES, December 23, 2025 /EINPresswire.com/ -- Cellens, Inc., a cancer diagnostics company pioneering a new mechanobiology and AI-driven platform, BioFeel™, for non-invasive cancer detection, has raised a $6.5M Series Seed round. …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
